Javascript must be enabled to continue!
Determination of Radiochemical Purity of 99mTc-DTPA Using One-System Method of Paper Chromatography
View through CrossRef
The more efficient and effective quality control techniques for 99mTc-DTPA are needed because 99mTc has a short half-life of around 6.0 hours. We have succeeded in developing a one-system of Thin Layer Chromatography (TLC) for radiochemical purity testing system that is faster and more practical. Two-system method of TLC for radiochemical purity testing uses mobile phase of methyl ethyl ketone indicated as system A and 0.9% sodium chloride solution indicated as system B. One-system method uses the mobile phase of a mixture solution of acetone and 0.9% sodium chloride. In this study, the determination of radiochemical purity of the one-system of TLC has been successfully developed using the Whatman-1 paper stationary phase and the mixture of mobile phase between acetone and 0.9% sodium chloride solution. The mobile phase of acetone: 0.9% sodium chloride with a ratio of 9:1 shows the most optimum results. This phase can separate 99mTc-DTPA (Rf = 0.4-0.6) from 99mTcO4- (Rf = 0.9-1.0) and 99mTcO2 (Rf = 0.0-0.1) as radiochemical impurities. This result shows that the one-system of TLC method can be used for radiochemical purity testing of 99mTc-DTPA radiopharmaceutical kits. This method can completely separate the product compound (99mTc-DTPA) from its impurities (99mTcO2 and 99mTcO4-).
Title: Determination of Radiochemical Purity of 99mTc-DTPA Using One-System Method of Paper Chromatography
Description:
The more efficient and effective quality control techniques for 99mTc-DTPA are needed because 99mTc has a short half-life of around 6.
0 hours.
We have succeeded in developing a one-system of Thin Layer Chromatography (TLC) for radiochemical purity testing system that is faster and more practical.
Two-system method of TLC for radiochemical purity testing uses mobile phase of methyl ethyl ketone indicated as system A and 0.
9% sodium chloride solution indicated as system B.
One-system method uses the mobile phase of a mixture solution of acetone and 0.
9% sodium chloride.
In this study, the determination of radiochemical purity of the one-system of TLC has been successfully developed using the Whatman-1 paper stationary phase and the mixture of mobile phase between acetone and 0.
9% sodium chloride solution.
The mobile phase of acetone: 0.
9% sodium chloride with a ratio of 9:1 shows the most optimum results.
This phase can separate 99mTc-DTPA (Rf = 0.
4-0.
6) from 99mTcO4- (Rf = 0.
9-1.
0) and 99mTcO2 (Rf = 0.
0-0.
1) as radiochemical impurities.
This result shows that the one-system of TLC method can be used for radiochemical purity testing of 99mTc-DTPA radiopharmaceutical kits.
This method can completely separate the product compound (99mTc-DTPA) from its impurities (99mTcO2 and 99mTcO4-).
Related Results
Non-Invasive Measurement of Microvascular Permeability to a Small Solute in Man: Validation of the Technique
Non-Invasive Measurement of Microvascular Permeability to a Small Solute in Man: Validation of the Technique
1. The purpose of the study was to evaluate a non-invasive technique for measurement of microvascular permeability to a small hydrophilic solute.
2. The technique me...
Comparative Kinetics of Microvascular Inulin and 99mTc-Labelled Diethylenetriaminepenta-Acetic Acid Exchange
Comparative Kinetics of Microvascular Inulin and 99mTc-Labelled Diethylenetriaminepenta-Acetic Acid Exchange
1. After simultaneous intravenous injection as a mixture, 99mTc-labelled diethylenetriaminepentaacetic acid (99mTc-DTPA; molecular mass 492 Da) and inulin (∼6000 Da) gave arterial ...
Pharmacokinetic Evaluation of 99mTc-radiolabeled Solid Lipid Nanoparticles and Chitosan Coated Solid Lipid Nanoparticles
Pharmacokinetic Evaluation of 99mTc-radiolabeled Solid Lipid Nanoparticles and Chitosan Coated Solid Lipid Nanoparticles
Background:
Solid Lipid Nanoparticles (SLNs) possess unique in vivo features such as high resistivity,
bioavailability, and habitation at the target site. Coating nanoparticles wit...
QUALITATIVE COMPARISON OF LOCALLY PREPARED 99mTc-LABELED METHYLENE DIPHOSPHONATE AND 99mTc-LABELED PYROPHOSPHATE
QUALITATIVE COMPARISON OF LOCALLY PREPARED 99mTc-LABELED METHYLENE DIPHOSPHONATE AND 99mTc-LABELED PYROPHOSPHATE
Different parameters affecting labeling of 99mTc with two compounds were studied in order to standardize the procedure for the preparation of 99mTc -MDP and 99mTc -PYP. Briefly rad...
Evaluation of Surgical Outcome of Pelviureteric Junction Obstructive Patients by 99mTc-DTPA Renography
Evaluation of Surgical Outcome of Pelviureteric Junction Obstructive Patients by 99mTc-DTPA Renography
Objectives: Pelviureteric junction (PUJ) obstruction is the most common congenital abnormality of urinary tract and accounts for about 80% cases. 99mTc-DTPA renography with diureti...
Interpretation of Enhanced Fecal and Urinary Plutonium Excretions Under a 2-year Regular DTPA Treatment Started Months after Intake: A Case Report.
Interpretation of Enhanced Fecal and Urinary Plutonium Excretions Under a 2-year Regular DTPA Treatment Started Months after Intake: A Case Report.
Abstract
Background: Internal contamination with plutonium is a potential hazard for workers handling this alpha-emitting transuranic element. The only medical approach ava...
Comparative Evaluation of Renoscintigraphic Properties and Plasma Clearance of 99mTc-DADS (99mTc-N,N‘ -bis/Mercaptoacetamido Ethylenediamine), 99mTc-DTPA and 131I-o-Hippuran
Comparative Evaluation of Renoscintigraphic Properties and Plasma Clearance of 99mTc-DADS (99mTc-N,N‘ -bis/Mercaptoacetamido Ethylenediamine), 99mTc-DTPA and 131I-o-Hippuran
Plasma clearance of 99mTc-N,N’-bis (1,2-mercaptoacetamido) ethylenediamine (DADS), 99mTc-DTPA and 131I-o-hippuran (OIH) was determined in rabbits from blood-concentration decay cur...
Non-Invasive Mycobacterium avium Detection Using 99mTc-GSA on Single-Photon Emission Computed Tomography
Non-Invasive Mycobacterium avium Detection Using 99mTc-GSA on Single-Photon Emission Computed Tomography
Background: The prevalence of nontuberculous mycobacteria (NTM) infection is on the rise, surpassing that of pulmonary tuberculosis in Japan. Current standard therapy for NTM infec...

